Early Value Assessments for MedTech by NICE

This document is a technical report that outlines the Early Value Assessment (EVA) program initiated by NICE for evaluating medical technologies. The EVA program aims to facilitate the identification of technologies that provide the best value for money and ensure early patient access within the NHS. The report details the methodologies used in the assessment, including the evaluation of clinical effectiveness and economic evidence for various technologies. It presents findings from 14 EVAs, which include 10 digital technologies and 4 diagnostics, highlighting the types of technologies assessed, the recommendations made, and the evidence reviewed. The report also discusses the strengths and limitations of the technologies evaluated, noting that while some technologies have been recommended for use, others require further data collection to support their clinical or cost benefits. The document concludes with an overview of the therapy areas covered by the EVAs and the implications for future assessments.